World / Cardiology
18.06.2008 17:13
medicalnewstoday.com
Patients in the European Union (EU) with arrhythmias, also known as irregular heart rhythms, may now benefit from treatment with a new state-of-the art catheter, designed to reduce char and thrombus formation during ablation and give physicians improved range of motion during procedures to eliminate abnormal heart rhythms. The new EZ STEER™ THERMOCOOL® Bi-Directional Catheter, manufactured by Biosense Webster, Inc.
World
Cardiology
English
Українська
Русский
Date: 09 January 2009 - 20:32
Number of sources in English: 130